CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-14 | Virgin Herbert EVP, Research & CSO | Option exercise | +3,805 | $1.53 | $6K | 3,805 |
| 2020-05-14 | Virgin Herbert EVP, Research & CSO | Sale | −3,805 | $30.07 | $114K | 0 |
| 2020-05-14 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −3,805 | 551,750 | ||
| 2020-05-14 | Parrish Jay Chief Business Officer | Option exercise | +75,000 | $1.49 | $111K | 297,222 |
| 2020-05-14 | Parrish Jay Chief Business Officer | Sale | −75,000 | $30.05 | $2.3M | 222,222 |
| 2020-05-14 | Parrish Jay Chief Business Officer | Option exercise · Stock Option (Right to Buy) | −75,000 | 147,221 | ||
| 2020-05-01 | MORE ROBERT J Director | Sale | −15,758 | $27.90 | $440K | 74,234 |
| 2020-05-01 | MORE ROBERT J Director | Sale | −2,700 | $28.60 | $77K | 71,534 |
| 2020-04-17 | Pang Phillip Chief Medical Officer | Option exercise | +8,000 | $0.86 | $7K | 15,777 |
| 2020-04-17 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −8,000 | 95,333 | ||
| 2020-04-14 | SCANGOS GEORGE A President and CEO | Other disposition | −236,806 | $29.56 | $7.0M | 1,907,329 |
| 2020-04-14 | SCANGOS GEORGE A President and CEO | Other acquisition | +236,806 | $29.56 | $7.0M | 4,713,559 |
| 2020-02-25 | Horn Howard CFO | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-12-10 | Ramasastry Saira Director | Grant or award · Stock Option (Right to Buy) | +57,777 | 57,777 | ||
| 2019-10-16 | Burow Kristina Director | Conversion | +11,666,665 | 12,111,109 | ||
| 2019-10-16 | Burow Kristina Director | Conversion | +15,555,554 | 15,555,554 | ||
| 2019-10-16 | Burow Kristina Director | Purchase | +1,000,000 | $20.00 | $20.0M | 1,000,000 |
| 2019-10-16 | Burow Kristina Director | Conversion · Series A-1 Convertible Preferred Stock | −11,111,110 | 0 | ||
| 2019-10-16 | Burow Kristina Director | Conversion · Series A-1 Convertible Preferred Stock | −13,333,332 | 0 | ||
| 2019-10-16 | Burow Kristina Director | Conversion · Series B Convertible Preferred Stock | −555,555 | 0 |
Page 57 of 61 · 1,204 trades